Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance

International Archives of Allergy and Immunology

Volumn 144, Issue 3, 2007, Pages 226-230

  Asero, Riccardo ^a,b  

^a CLINICA SAN CARLO   (Italy)

^b Ospedale 21   (Italy)

Author keywords

Allergy, drug; Nonsteroidal anti inflammatory drugs; Skin testing; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHENAZONE; CYCLOOXYGENASE 1 INHIBITOR; DICLOFENAC; ETORICOXIB; FEPRAZONE; KETOPROFEN; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDYPYRINE; PARACETAMOL; PIROXICAM; PYRAZOLONE; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; MALE; PREDICTION; PRIORITY JOURNAL; SKIN TEST; URTICARIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SKIN TESTS; URTICARIA;

EID: 35348842776     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103996     Document Type: Article

References (32)

1. Stevenson DD, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-180.
2. Stevenson DD, Simon RA, Zuraw BL: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs;in Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Allergy: Principles and Practice, ed 6. St Louis, Mosby, 2003, pp 1695-1710.
3. Papa G, Romano A, Del Bono A, Quaratino D, Di Fonso M, et al: Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997;78:74-78.
4. Quaratino D, Romano A, Papa G, Di Fonso M, Giuffreda F, et al: Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997;79:47-50.
5. Pastorello EA, Zara C, Riario-Sforza GG, Pravettoni V, Incorvaia C: Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998;53:880-884.
6. Nettis E, Di Paola R, Ferrannini A, Tursi A: Meloxicam in hypersensitivity to NSAID. Allergy 2001;56:803-804.
7. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR: Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201-204.
8. Nettis E, Di Paola R, Napoli G, Ferrannini A, Tursi A: Benzydamine: an alternative nonsteroidal anti-inflammatory drug in patients with nimesulide-induced urticaria. Allergy 2002;57:442-445.
9. Nettis E, Di Paola R, Ferrannini A, Tursi A: Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;88:331-334.
10. Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R: Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal antiinflammatory drugs. Clin Exp Allergy 2002;32:397-400.
11. Perrone MR, Artesani MC, Viola M, Gaeta F, Caringi M, Quaratino D, Romano A: Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review. Int Arch Allergy Immunol 2003;132:82-86.
12. Asero R: Oral aspirin challenges in patients with a history of intolerance to single nonsteroidal anti-inflammatory drug. Clin Exp Allergy 2005;35:713-716.
13. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW: A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br J Dermatol 1986;114:583-590.
14. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988;90:213-217.
15. Grattan CEH, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991;21:695-704.
16. Greaves MW: Chronic urticaria. N Engl J Med 1995;332:1767-1772.
17. Greaves MW, O'Donnell B: Urticaria causes and treatment. Int J Immunopathol Pharmacol 1997;99:461-465.
18. Hide M, Fancis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
19. Asero R, Tedeschi A, Lorini M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann Allergy Asthma Immunol 2002;88:468-472.
20. Asero R, Tedeschi A, Lorini M, Caldironi G, Barocci F: Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors. Int Arch Allergy Immunol 2003;131:195-200.
21. Asero R, Tedeschi A, Riboldi P, Cugno M: Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-andflare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006;117:1113-1117.
22. Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, Marzano AV, Fanoni D, Cugno M: Activation of the tissue pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007;119:705-710.
23. Schaeffer RC, Gong F, Bitrick MS, Smith TL: Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 1993;264:1798-1809.
24. Cirino G, Cicala C, Bucci MR, Sorrentino L, Maranganore JM, Stone SR: Thrombin functions as an inflammatory mediator through activation of its receptors. J Exp Med 1996;183:821-827.
25. Nobe K, Sone T, Paul RJ, Honda K: Thrombin-induced force development in vascular endothelial cells: contribution to alteration of permeability mediated by calcium-dependent and -independent pathways. J Pharmacol Sci 2005;99:252-263.
26. Razin E, Marx G: Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J Immunol 1984;133:3282-3285.
27. Vliagoftis H: Thrombin induces mast cell adhesion to fibronectin: evidence for the involvement of protease-activated receptor-1. J Immunol 2002;169:4551-4558.
28. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA: Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006;12:682-687.
29. Asero R: Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria. Ann Allergy Asthma Immunol 2006;97:187-189.
30. Goldman L: Quantitative aspects of clinical reasoning;in Wilson JD, Braunwald E, Isselbacher KJ, et al. (eds): Principles of Internal Medicine. New York, McGraw-Hill, 1987, pp 5-11.
31. Asero R, Tedeschi A, Riboldi P, Cugno M: Patients with multiple drug allergy syndrome show signs of thrombin generation similarly to patients with chronic urticaria. Ann Allergy Asthma Immunol, submitted.
32. Asero R: Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003;111:1095-1098.